Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
Jorge Matías‐Guiu, Jorge Matías‐Guiu, Paloma Montero‐Escribano, Vanesa Pytel, J. Porta‐Etessam, Jordi A. Matias-Guiu, Jordi A. Matias-Guiu
Topics & Concepts
AlemtuzumabMedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseLymphocyteImmune systemImmunologyInfectious disease (medical specialty)TransplantationLong-Term Effects of COVID-19Multiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 Research